513 related articles for article (PubMed ID: 27650065)
1. Apelin/APJ system as a therapeutic target in diabetes and its complications.
Hu H; He L; Li L; Chen L
Mol Genet Metab; 2016 Sep; 119(1-2):20-7. PubMed ID: 27650065
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic potentials of apelin in obesity-associated diseases.
Castan-Laurell I; Dray C; Valet P
Mol Cell Endocrinol; 2021 Jun; 529():111278. PubMed ID: 33838166
[TBL] [Abstract][Full Text] [Related]
3. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
Huang Z; He L; Chen Z; Chen L
J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
[TBL] [Abstract][Full Text] [Related]
4. Apelin receptors: From signaling to antidiabetic strategy.
Chaves-Almagro C; Castan-Laurell I; Dray C; Knauf C; Valet P; Masri B
Eur J Pharmacol; 2015 Sep; 763(Pt B):149-59. PubMed ID: 26007641
[TBL] [Abstract][Full Text] [Related]
5. Apelin/APJ system: A novel therapeutic target for locomotor system diseases.
Luo J; Liu W; Feng F; Chen L
Eur J Pharmacol; 2021 Sep; 906():174286. PubMed ID: 34174264
[TBL] [Abstract][Full Text] [Related]
6. The apelin/APJ system as a therapeutic target in metabolic diseases.
Castan-Laurell I; Masri B; Valet P
Expert Opin Ther Targets; 2019 Mar; 23(3):215-225. PubMed ID: 30570369
[TBL] [Abstract][Full Text] [Related]
7. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.
Dray C; Debard C; Jager J; Disse E; Daviaud D; Martin P; Attané C; Wanecq E; Guigné C; Bost F; Tanti JF; Laville M; Vidal H; Valet P; Castan-Laurell I
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1161-9. PubMed ID: 20233941
[TBL] [Abstract][Full Text] [Related]
8. Multiple roles of apelin/APJ system in eye diseases.
Luo J; Zhao Q; Li Z; Chen L
Peptides; 2022 Jun; 152():170767. PubMed ID: 35181348
[TBL] [Abstract][Full Text] [Related]
9. L-carnitine improves metabolic disorders and regulates apelin and apelin receptor genes expression in adipose tissue in diabetic rats.
Ranjbar Kohan N; Tabandeh MR; Nazifi S; Soleimani Z
Physiol Rep; 2020 Dec; 8(23):e14641. PubMed ID: 33278072
[TBL] [Abstract][Full Text] [Related]
10. Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases.
Zhong JC; Zhang ZZ; Wang W; McKinnie SMK; Vederas JC; Oudit GY
Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1942-1950. PubMed ID: 27825851
[TBL] [Abstract][Full Text] [Related]
11. Expanding role for the apelin/APJ system in physiopathology.
Carpéné C; Dray C; Attané C; Valet P; Portillo MP; Churruca I; Milagro FI; Castan-Laurell I
J Physiol Biochem; 2007 Dec; 63(4):359-73. PubMed ID: 18457011
[TBL] [Abstract][Full Text] [Related]
12. Apelin/APJ system: A bifunctional target for cardiac hypertrophy.
Lu L; Wu D; Li L; Chen L
Int J Cardiol; 2017 Mar; 230():164-170. PubMed ID: 27979574
[TBL] [Abstract][Full Text] [Related]
13. Apelin, diabetes, and obesity.
Castan-Laurell I; Dray C; Attané C; Duparc T; Knauf C; Valet P
Endocrine; 2011 Aug; 40(1):1-9. PubMed ID: 21725702
[TBL] [Abstract][Full Text] [Related]
14. Apelin/APJ system: A novel promising target for anti-aging intervention.
Zhou Q; Chen L; Tang M; Guo Y; Li L
Clin Chim Acta; 2018 Dec; 487():233-240. PubMed ID: 30296443
[TBL] [Abstract][Full Text] [Related]
15. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.
O'Carroll AM; Lolait SJ; Harris LE; Pope GR
J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882
[TBL] [Abstract][Full Text] [Related]
16. Apelin/APJ system: an emerging therapeutic target for respiratory diseases.
Yan J; Wang A; Cao J; Chen L
Cell Mol Life Sci; 2020 Aug; 77(15):2919-2930. PubMed ID: 32128601
[TBL] [Abstract][Full Text] [Related]
17. Apelin/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases.
Cheng J; Luo X; Huang Z; Chen L
J Cell Physiol; 2019 Aug; 234(8):12149-12160. PubMed ID: 30585633
[TBL] [Abstract][Full Text] [Related]
18. Apelin/APJ system: A critical regulator of vascular smooth muscle cell.
Luo X; Liu J; Zhou H; Chen L
J Cell Physiol; 2018 Jul; 233(7):5180-5188. PubMed ID: 29215755
[TBL] [Abstract][Full Text] [Related]
19. Apelin/APJ system: A novel promising therapy target for pathological angiogenesis.
Wu L; Chen L; Li L
Clin Chim Acta; 2017 Mar; 466():78-84. PubMed ID: 28025030
[TBL] [Abstract][Full Text] [Related]
20. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
Kuba K; Sato T; Imai Y; Yamaguchi T
Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
